ATE300542T1 - 1-glyoxlylamidindolizine zur behandlung von krebs - Google Patents

1-glyoxlylamidindolizine zur behandlung von krebs

Info

Publication number
ATE300542T1
ATE300542T1 AT02798231T AT02798231T ATE300542T1 AT E300542 T1 ATE300542 T1 AT E300542T1 AT 02798231 T AT02798231 T AT 02798231T AT 02798231 T AT02798231 T AT 02798231T AT E300542 T1 ATE300542 T1 AT E300542T1
Authority
AT
Austria
Prior art keywords
substituted
group
unsubstituted
independently
aryl group
Prior art date
Application number
AT02798231T
Other languages
German (de)
English (en)
Inventor
Keizo Koya
Lijun Sun
Mitsunori Ono
Weiwen Ying
Hao Li
Original Assignee
Synta Pharmaceuticals Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synta Pharmaceuticals Corp filed Critical Synta Pharmaceuticals Corp
Application granted granted Critical
Publication of ATE300542T1 publication Critical patent/ATE300542T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT02798231T 2001-09-13 2002-09-13 1-glyoxlylamidindolizine zur behandlung von krebs ATE300542T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32202001P 2001-09-13 2001-09-13
PCT/US2002/029154 WO2003022846A1 (en) 2001-09-13 2002-09-13 1-glyoxlylamide indolizines for treating cancer

Publications (1)

Publication Number Publication Date
ATE300542T1 true ATE300542T1 (de) 2005-08-15

Family

ID=23253054

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02798231T ATE300542T1 (de) 2001-09-13 2002-09-13 1-glyoxlylamidindolizine zur behandlung von krebs

Country Status (19)

Country Link
US (2) US6861436B2 (enExample)
EP (1) EP1432709B8 (enExample)
JP (1) JP2005504795A (enExample)
KR (1) KR20040053125A (enExample)
CN (1) CN1568324A (enExample)
AT (1) ATE300542T1 (enExample)
AU (1) AU2002333626B2 (enExample)
BR (1) BR0212794A (enExample)
CA (1) CA2459886A1 (enExample)
DE (1) DE60205265T2 (enExample)
ES (1) ES2245747T3 (enExample)
IL (1) IL160810A0 (enExample)
IS (1) IS7176A (enExample)
MX (1) MXPA04002323A (enExample)
NO (1) NO20041035L (enExample)
NZ (1) NZ531700A (enExample)
PT (1) PT1432709E (enExample)
WO (1) WO2003022846A1 (enExample)
ZA (1) ZA200401996B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040116462A1 (en) * 2002-12-12 2004-06-17 Mitsunori Ono Indolizine compounds
PT1432709E (pt) * 2001-09-13 2005-10-31 Synta Pharmaceuticals Corp Indolizinas de 1-glioxilamida para o trtamento do cancro
JP2006504692A (ja) * 2002-09-13 2006-02-09 シンタ ファーマシューティカルズ コーポレーション インドリジンの合成方法
DE10318611A1 (de) 2003-04-24 2004-11-11 Elbion Ag 4-, 6- oder 7-Hydroxyindole mit N-Oxidgruppen und deren Verwendung als Therapeutika
WO2005099824A1 (en) * 2004-03-30 2005-10-27 Synta Pharmaceuticals, Corp. 1-glyoxylamide indolizines for treating lung and ovarian cancer
GB0413605D0 (en) 2004-06-17 2004-07-21 Addex Pharmaceuticals Sa Novel compounds
US20070293456A9 (en) * 2004-12-30 2007-12-20 Anthony Hayford Method for the synthesis of 3-substituted indolizine and benzoindolizine compounds
WO2006128184A2 (en) * 2005-05-20 2006-11-30 Alantos-Pharmaceuticals, Inc. Pyrimidine or triazine fused bicyclic metalloprotease inhibitors
US20070155738A1 (en) 2005-05-20 2007-07-05 Alantos Pharmaceuticals, Inc. Heterobicyclic metalloprotease inhibitors
CA2733247C (en) * 2008-08-14 2018-04-03 Beta Pharma Canada Inc. Heterocyclic amide derivatives as ep4 receptor antagonists
EP4008327A1 (en) 2009-04-29 2022-06-08 Amarin Pharmaceuticals Ireland Limited Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
AR077428A1 (es) * 2009-07-29 2011-08-24 Sanofi Aventis (aza) indolizinacarboxamidas ciclicas su preparacion y su uso como agentes farmaceuticos
CN113603694B (zh) * 2021-07-16 2022-07-22 浙江工业大学 一种1,2-二酮类化合物及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2287706A (en) * 1994-03-21 1995-09-27 Fujisawa Pharmaceutical Co Indolizine derivatives
FR2757166B1 (fr) * 1996-12-12 1999-01-29 Rhone Poulenc Rorer Sa Derives du pyrrole, leur preparation et les compositions pharmaceutiques qui les contiennent
WO1998047507A1 (en) * 1997-04-24 1998-10-29 Shionogi & Co., Ltd. Method for the treatment of stroke using n-heterocyclic glyoxylamide compounds
US6472389B1 (en) 1998-05-21 2002-10-29 Shionogi & Co., Ltd. Pyrrolo[1,2-b] pyridazine derivatives having sPLA2 inhibitory effect
CA2346334A1 (en) 1998-10-14 2000-04-20 Shionogi & Co., Ltd. Composition for treating or preventing ischemia reperfusion injury
US6461538B2 (en) * 1999-12-16 2002-10-08 Fuji Photo Film Co., Ltd. Production process for indolizine compounds and their use in organic light-emitting devices
PT1432709E (pt) * 2001-09-13 2005-10-31 Synta Pharmaceuticals Corp Indolizinas de 1-glioxilamida para o trtamento do cancro
US20040116462A1 (en) * 2002-12-12 2004-06-17 Mitsunori Ono Indolizine compounds

Also Published As

Publication number Publication date
IL160810A0 (en) 2004-08-31
CA2459886A1 (en) 2003-03-20
NO20041035L (no) 2004-04-30
AU2002333626B2 (en) 2006-06-29
DE60205265T2 (de) 2006-03-30
KR20040053125A (ko) 2004-06-23
ZA200401996B (en) 2005-05-31
MXPA04002323A (es) 2005-04-08
EP1432709B1 (en) 2005-07-27
EP1432709A1 (en) 2004-06-30
US6861436B2 (en) 2005-03-01
JP2005504795A (ja) 2005-02-17
EP1432709B8 (en) 2005-11-02
IS7176A (is) 2004-03-11
ES2245747T3 (es) 2006-01-16
WO2003022846A1 (en) 2003-03-20
HK1063322A1 (en) 2004-12-24
DE60205265D1 (de) 2005-09-01
PT1432709E (pt) 2005-10-31
BR0212794A (pt) 2004-10-05
CN1568324A (zh) 2005-01-19
US20030153759A1 (en) 2003-08-14
NZ531700A (en) 2006-10-27
US20040214850A1 (en) 2004-10-28

Similar Documents

Publication Publication Date Title
DE60205265D1 (de) 1-glyoxlylamidindolizine zur behandlung von krebs
AR043158A1 (es) Compuestos activadores de glucoquinasa de amida tri(ciclo) sustituidos, procedimientos para su preparacion y composiciones farmaceuticas que los contienen
PE20040164A1 (es) Mimeticos de glucocorticoides, procedimientos para su preparacion y composiciones farmaceuticas
EA200700141A1 (ru) Новые аминоциклические производные мочевины, их получение и фармацевтическое применение в качестве ингибиторов киназы
NO20050418L (no) Kondenserte pyridiner og pyrimidiner med TIE2(TEK) aktivitet
TW200800949A (en) Macrocylic inhibitors of hepatitis C virus
ATE326454T1 (de) Neue bernsteinsäure derivative als cysteine- protease-inhibitoren
CO5590895A2 (es) Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos
ATE90107T1 (de) Peptide mit collagenase hemmender wirkung.
CO5590960A2 (es) Derivados de azaindolilalquilamina como ligandos de 5- hidroxitriptamina-6
EA200300982A1 (ru) Гетероциклические производные для лечения рака и других пролиферативных заболеваний
ES2038678T3 (es) Procedimiento para la preparacion de n-(2-alquil-3-mercapto-glutaril)-alfamino-acidos.
AR043487A1 (es) Heterociclos fusionados de pirimidina y usos de los mismos
AR042002A1 (es) Benzoxazinonas sustituidas, proceso de obtencion y usos para tratamiento de enfermedades del sistema nervioso central.
DK471586D0 (da) 3-vinyl- og 3-ethynyl-beta-carbolinderivater, deres fremstilling og deres anvendelse som laegemiddel
ATE482933T1 (de) Sulfopyrrolderivate
HUP0201475A2 (hu) Heteroarilamidin-, metilamidin- és guanidinszármazékok, előállításuk és alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények
DK1303512T3 (da) Fremgangsmåde til fremstilling af arylacetylaminothiazoler
DK118287D0 (da) Heteroaryloxy-beta-carbolinderivater, deres fremstilling og deres anvendelse som laegemiddel
MXPA04000978A (es) Procedimiento para la produccion de 4-amino-2,5-bisheterociclilquinazolinas.
AR036735A1 (es) Derivados de 5-metoxi-8-aril-[1,2,4]triazolo[1,5-a]piridina
Schantl et al. Expedient synthesis of N-substituted 2-aminothiazoles
TW200602039A (en) 1-Glyoxylamide indolizines for treating lung and ovarian cancer
ES435955A1 (es) Un procedimiento para obtener un derivado de pirido (3,4-d) piridezina.
ATE234815T1 (de) Aminopyrrolidin-derivate, verfahren zur ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1432709

Country of ref document: EP

REN Ceased due to non-payment of the annual fee